NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...

MPox disease, caused by the human Mpox virus (hMPXV) has been causing a regional ... activity against an orthopoxvirus in an animal model that is considered an important model to establish ...